Junshi Biosciences Announces JAMA Publication of Results from NEOTORCH, a Randomized Phase 3 Trial of Perioperative Toripalimab plus Chemotherapy for Patients with Resectable Non-Small Cell Lung Cancer
This part is Partnership Content material equippedThe content material on this part is equipped by GlobeNewswire for the needs of ...